Obesity
Obesity is a complex chronic disease that requires long term management. It is among the leading risk factors for several cardio-metabolic diseases such as heart disease, ischemic stroke, liver diseases incl. NASH and type 2 diabetes, as well as for a number of cancers. Obesity continue to rise, and by 2030 it is predicted that one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity (BMI ≥30kg/m2 ) by 2030. The number of people with obesity is on course to double since 2010.
Latest Article on Obesity
Related Press Releases
Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Phase 2 Clinical Testing in NASH and Obesity